“On the forefront of getting reliable, affordable, data driven and ethical cures to market, there is ARIRDMSCRO. We bring a vibrant, quality driven, regulatory compliant strongly appreciated scientific and clinical expertise, with speed to the development of the new drugs and medical devices, as well as PMS or PASS studies for approved Generic treatment options (as modeled extended phase IV studies) for better affordability. We conduct clinical trials in allopathic new drugs or generic drugs, along with Ayurvedic clinical trials ( as direct Phase 2, 3a, 3b) or Elongated safety assessment studies (PMS or PASS) to match growing need of our population in India, living in various socio economic strata and having different needs for affordable cure. This enables us to address the challenging concern which we are currently facing in India and across the Globe.

ARIRDMSCRO is a niche start-up Indian contract research organization providing comprehensive, clinical operations, Project Management and complete lifecycle clinical trials/Studies management services. Our clients and partners include pharmaceutical, biotechnology, medical device, ayurvedic pharmaceuticals, and academic and government organizations. We customize our solution oriented approach for successful clinical trials management by having our resources in various cities in India and able to work in most challenged times (as of COVID -19Lockdown). We are leveraging our capabilities and experience to match our client needs and expectations. For achieving the agreed set of objectives, we constantly strive with our innovative technologies, therapeutic expertise to help clients and partners, reduce the cost and time bell-curve of drug development.